Understanding Tardive Dyskinesia: What you need to know

Tardive Dyskinesia (TD) – a neurological disorder associated with prolonged use of antipsychotic medications – affects over 600,000 people annually.

Wondering what this means for the people you serve?

Genoa Healthcare recently hosted a webinar to discuss risk factors associated with TD, diagnostic criteria and assessment of TD, and approaches to managing and mitigating the symptoms. The webinar also covered costs and clinical outcomes of treatment options for consumers living with TD.

Watch the recording here: